The artificial intelligence (AI) revolution seems to pick up pace from one week to the next, but what does it mean for the pharmaceutical sector?

A Food and Drug Administration advisory panel on Monday endorsed the experimental Alzheimer’s drug donanemab, which studies showed slowed early stages of the fatal mind-robbing

Around 25 million Americans are affected by the eye disease Demodex blepharitis, which is caused by small mites that make their way into the eyelid. This causes chronic

April 4 (Reuters) – Amylyx Pharmaceuticals (AMLX.O), opens new tab will withdraw its amyotrophic lateral sclerosis (ALS) drug – its only product in the market – from

Artificial intelligence has emerged as a double-edged sword for pharmaceutical companies, helping to develop new cures while also creating obstacles to obtaining drug patents potentially

PLYMOUTH, Minn.–(BUSINESS WIRE)–SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for epidural